Latest News

Thu, February 4, 2010
KDMC Plans Family Fun Day in Recognition of Heart Month
“Be Good to your Heart” is the common theme throughout King’s Daughters Medical Center’s February celebration of Heart Month. Special activities will include Family Fun Day 10 a.m. to 2 p.m. Saturday, Feb. 13, at the Center Court area of Kyova Mall, Cannonsburg.

Fri, January 29, 2010
Free Healthy Heart Screening Feb. 18 at Fort Gay, WV
With jobs, spouses, kids and grandkids, church and other activities, the demands of daily life can be rough. Sometimes, it’s difficult to find a second to catch your breath, much less time to take care of your heart.But just a few minutes now could head off disaster later. So this February – American Heart Month – King’s Daughters Medical Center encourages you to find time for your heart. To make it easier, KDMC is offering a free, Healthy Heart Screening from 11 a.m. to 1 p.m. Thursday, Feb. 18 at the Fort Gay Community Center in Fort Gay, W.Va.

Fri, January 29, 2010
Free Healthy Heart Screening Feb. 11 at South Point, Ohio
With jobs, spouses, kids and grandkids, church and other activities, the demands of daily life can be rough. Sometimes, it’s difficult to find a second to catch your breath, much less time to take care of your heart.But just a few minutes now could head off disaster later. So this February – American Heart Month – King’s Daughters Medical Center encourages you to find time for your heart. To make it easier, KDMC is offering a free, Healthy Heart Screening from 10 a.m. to noon, Thursday, Feb. 11, at the Walmart in South Point, Ohio.

Recently Added Trials

OptiVol Care Pathway

To compare monthly versus quarterly review of CardiacCompass Trends with OptiVol for initiation of clinical action.    

APPRAISE 2

To determine if apixaban is superior to placebo for preventing cardiovascular death, non-fatal myocardial infarction, or ischemic stroke in subjects with a recent acute coronary syndrome (ACS).    

DAPT

To assess the effectiveness and sefety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing Percutaneous coronary intervention.    

DETERMINE

To determine if Implantable Cardioverter Defibrillator therapy in combination with medical therapy in patients with an infarct size greater than or equal to 10 percent of the left ventricular mass improves long term survival compared to medical therapy alone.